RCUS
Arcus Biosciences Inc
25.20$
-1.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +491.2% | +79.6% | +420.0% | +391.0% | -70.8% | +4.5% | +120.5% | -4.3% | |
| – | +98.8% | +1,800.7% | +58.1% | +102.6% | -95.6% | +98.4% | +2,328.6% | -97.1% | +0.0% | |
| – | – | +491.2% | +79.6% | +420.0% | +391.0% | -70.8% | +4.5% | +120.5% | -8.1% | |
| – | +231.4% | +5.1% | +58.1% | +102.6% | +61.6% | +12.1% | +18.1% | +31.8% | +16.7% | |
| – | +94.1% | +77.7% | +86.0% | +70.4% | +67.4% | +44.4% | +12.5% | +2.6% | -8.3% | |
| – | +225.2% | +15.2% | +64.1% | +94.8% | +62.9% | +19.1% | +16.6% | +28.7% | +6.0% | |
| – | – | – | – | – | – | -618.5% | – | – | – | |
| – | – | – | -100.0% | – | – | +669.2% | +0.0% | +100.0% | +100.0% | |
| – | – | – | – | – | – | -583.6% | – | – | – | |
| – | – | – | -266.7% | – | – | -50.0% | +500.0% | -83.3% | – | |
| – | – | – | – | – | – | -603.8% | – | – | – | |
| – | – | – | – | – | – | -537.3% | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.